Bispecific antibodies in colorectal cancer therapy: recent insights and emerging concepts.

Colorectal cancer (CRC) is identified as a life-threatening malignancy. Despite several efforts and proceedings available for CRC therapy, it is still a health concern. Among a vast array of novel therapeutic procedures, employing bispecific antibodies (BsAbs) is currently considered to be a promising approach for cancer therapy. BsAbs, as a large family of molecules designed to realize two distinct epitopes or antigens, can be beneficial microgadgets to target the tumor-associated antigen pairs. On the other hand, applying the immune system's capabilities to attack malignant cells has been proven as a tremendous development in cancer therapeutic projects. The current study has attempted to overview some of the approved BsAbs in CRC therapy and those under clinical trials. For this purpose, reputable scientific search engines and databases, such as PubMed, ScienceDirect, Google Scholar, Scopus, etc., were explored using the keywords 'bispecific antibodies', 'colorectal cancer', 'immunotherapy' and 'tumor markers'.

SR;NI Atom Transfer Radical Random Copolymerization of Styrene and Methyl Methacrylate:Incorporation of Diatomite Platelets.

Mesoporous diatomite platelets were employed to prepare various random poly (styrene-co-methyl methacrylate)/diatomite composites by in situ simultaneous reverse and normal initiation technique for atom transfer radical random copolymerization (SR&NI ATRP) technique. Nitrogen adsorption/desorption isotherm, SEM and TEM were employed for evaluating some inherent properties of the pristine diatomite platelets. Conversion and molecular weight determinations were carried out using GC and SEC respectively. Addition of 3 wt% diatomite platelets leads to increase of conversion from 76 to 92%. Molecular weight of poly (styrene-co-methyl methacrylate) chains increases from 12893 to 14907 g mol-1 by addition of 3 wt% mesoporous diatomite; however, polydispersity index values increases from 1.18 to 1.44. Copolymers composition was evaluated using 1H NMR spectroscopy. Increasing thermal stability of the nanocomposites is demonstrated by TGA. Differential scanning calorimetry shows an increase in glass transition temperature from 67.6 to 73.4 °C by adding 3 wt% of mesoporous diatomite platelets.

A Study on the Properties of Poly (Styrene-co-Methyl Methacrylate)/Silica Aerogel Nanocomposites Prepared via in situ SR&NI ATRP.

Simultaneous reverse and normal initiation technique for atom transfer radical copolymerization (SR&NI ATRP) of styrene and methyl methacrylate in the presence of hexamethyldisilazane (HMDS)-modified silica aerogel nanoparticles (H-SAN) and investigating the effect of addition of H-SAN on the copolymerization and thermal properties of the products are discussed. Some unique features of the H-SAN are evaluated using nitrogen adsorption/desorption isotherm, SEM and TEM. Conversion and molecular weight determinations were carried out using GC and SEC respectively. Adding of H-SAN by 3 wt% results in decrement of conversion from 94 to 73%. In addition, molecular weight of copolymer chains decreases from 19500 to 16000 g.mol-1. However, polydispersity index values increases from 1.29 to 1.65. Linear increase of ln(M0/M) with time for all the samples shows that copolymerization proceeds in a living manner. Increasing thermal stability of the nanocomposites is demonstrated by TGA. DSC results show a decrease in glass transition temperature from 70.3 to 63.5 °C by addition of 3 wt% H-SAN.

Controlled release of cefazolin sodium antibiotic drug from electrospun chitosan-polyethylene oxide nanofibrous Mats.

Antimicrobial electrospun chitosan-polyethylene oxide (CS-PEO) nanofibrous mats containing cefazolin, fumed silica (F. silica) and cefazolin-loaded fumed silica nanoparticles (NPs) were produced for biomedical applications. The FE-SEM images revealed that the F. silica and F. silica-cefazolin NPs had average diameters of 40±10 and 60±15nm, respectively. Also, the fibers diameters were approximately 160±30, 90±20 and 70±15nm for the pure CS-PEO, CS-PEO-1% F. silica and CS-PEO-1% F. silica-0.5% cefazolin nanofibrous mats, respectively indicating addition of F. silica and cefazolin loaded F. silica NPs to the CS-PEO mat led to decreasing the nanofiber diameter. Both of the CS-PEO mats containing 2.5% cefazolin and 1% F. silica-0.50% cefazolin showed 100% bactericidal activities against both S. aureus and E. coli bacteria. The cefazolin release from mats was sharply increased within first 24 and 6hours for the CS-PEO mats including 2.5% cefazolin and 1% F. silica-0.50% cefazolin but after that the drug was released very slowly. The improved hydrophilicity, higher tensile strength and sustained drug release for CS-PEO-1% F. silica-0.50% cefazolin suggested that it was the best nanocomposite tissue/device for biomedical applications among the mats CS-PEO-2.5% cefazolin and CS-PEO-1% F. silica. The wound healing ability of the CS-PEO-F. silica-cefazolin mat was evaluated on the wounded skins of the female Wistar rats and it was shown that the wounded skins of the rats were almost entirely healed after ten days using this mat as a wound dressing scaffold.

A novel chitosan-polyethylene oxide nanofibrous mat designed for controlled co-release of hydrocortisone and imipenem/cilastatin drugs.

Antimicrobial chitosan-polyethylene oxide (CS-PEO) nanofibrous mats containing ZnO nanoparticles (NPs) and hydrocortisone-imipenem/cilastatin-loaded ZnO NPs were produced by electrospinning technique. The FE-SEM images displayed that the spherical ZnO NPs were ∼70-200nm in size and the CS-PEO nanofibers were very uniform and free of any beads which had average diameters within the range of ∼20-130nm. For all of the nanofibrous mats, the water uptakes were the highest in acidic medium but they were decreased in the buffer and the least swellings were obtained in the alkaline environment. The drug incorporated mat preserved its bactericidal activity even after it was utilized in the release experiment for 8days in the PBS buffer. The hydrocortisone release was increased to 82% within first 12h while the release rate of imipenem/cilastatin was very much slower so that 20% of the drug was released during this period of time suggesting this nanofibrous mat is very suitable to inhibit inflammation (by hydrocortisone) and infection (using imipenem/cilastatin antibiotic and ZnO NPs) principally for the wound dressing purposes.

A 9-Month-Old Girl from Iran with Extensive Erythematous Plaques Due to Trichophyton simii, a Zoophilic Dermatophyte.

The incidence of dermatophytosis due to Trichophyton simii is generally considered to be limited to endemic areas, particularly one area of India. However, the high similarity between the morphological features of atypical T. simii isolates and those of other dermatophytes such as Trichophyton interdigitale and Arthroderma benhamiae may lead to misidentification of the cause of dermatophytosis in many instances. We investigated a rare case of tinea corporis in a 9-month-old female with extensive erythematous lesions. Morphological features of the recovered isolate from the culture resulted in the identification of Trichophyton interdigitale. For accurate identification, the internal transcribed spacer regions (ITS1 and ITS2) of the ribosomal DNA (rDNA) gene were sequenced and the isolate was ultimately identified as T. simii. In conclusion, T. simii, which has been formerly known to be restricted to specific endemic regions, appears to be not infrequent in non-endemic areas but instead simply less well-known and consequently underestimated. To determine its actual prevalence of infection, the application of DNA-based molecular methodologies is required.